These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 27277266)

  • 21. Power Doppler sonography assessment of tumor recurrence after chemoembolization therapy for hepatocellular carcinoma.
    Sumi S; Yamashita Y; Mitsuzaki K; Yamamoto H; Urata J; Nishiharu T; Takahashi M
    AJR Am J Roentgenol; 1999 Jan; 172(1):67-71. PubMed ID: 9888742
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical evaluation of power Doppler sonography for the diagnosis of hepatocellular carcinoma].
    Ohishi H; Hirai T; Yamada R; Hirohashi S; Honda N; Sakaguchi H; Matsuo N; Uchida H
    Nihon Igaku Hoshasen Gakkai Zasshi; 1996 May; 56(6):399-404. PubMed ID: 8710463
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Image fusion with volume navigation of contrast enhanced ultrasound (CEUS) with computed tomography (CT) or magnetic resonance imaging (MRI) for post-interventional follow-up after transcatheter arterial chemoembolization (TACE) of hepatocellular carcinomas (HCC): Preliminary results.
    Ross CJ; Rennert J; Schacherer D; Girlich C; Hoffstetter P; Heiss P; Jung W; Feuerbach S; Zorger N; Jung EM
    Clin Hemorheol Microcirc; 2010; 46(2-3):101-15. PubMed ID: 21135486
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Usefulness of contrast-enhanced perfusional sonography in the assessment of hepatocellular carcinoma hypervascular at spiral computed tomography.
    Gaiani S; Celli N; Piscaglia F; Cecilioni L; Losinno F; Giangregorio F; Mancini M; Pini P; Fornari F; Bolondi L
    J Hepatol; 2004 Sep; 41(3):421-6. PubMed ID: 15336445
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of image quality of contrast-enhanced power doppler imaging in hepatocellular carcinoma with the personal ultrasound imager: Comparison with the conventional machine.
    Wen YL; Kudo M; Minami Y; Chung H; Suetomi Y; Onda H; Kitano M; Kawasaki T; Maekawa K
    J Med Ultrason (2001); 2003 Mar; 30(1):31-8. PubMed ID: 27285152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The correlation between Doppler echography with a contrast medium and CT in the study of a hepatocarcinoma submitted to chemoembolization].
    Catalano O; Cusati B; Esposito M; Trivellini V; Lobianco R; Siani A
    Radiol Med; 1998 Jun; 95(6):608-13. PubMed ID: 9717543
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transrectal colour Doppler contrast sonography in the diagnosis of local recurrence after radical prostatectomy--comparison with MRI.
    Drudi FM; Giovagnorio F; Carbone A; Ricci P; Petta S; Cantisani V; Ferrari FS; Marchetti F; Passariello R
    Ultraschall Med; 2006 Apr; 27(2):146-51. PubMed ID: 16602039
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contrast-enhanced power Doppler sonography and helical computed tomography for assessment of vascularity of small hepatocellular carcinomas before and after percutaneous ablation.
    Vilana R; Llovet JM; Bianchi L; Sanchez M; Pagés M; Sala M; Gilabert R; Nicolau C; Garcia A; Ayuso C; Bruix J; Bru C;
    J Clin Ultrasound; 2003; 31(3):119-28. PubMed ID: 12594796
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vascularization of liver tumors - preliminary results with Coded Harmonic Angio (CHA), phase inversion imaging, 3D power Doppler and contrast medium-enhanced B-flow with second generation contrast agent (Optison).
    Jung EM; Kubale R; Jungius KP; Jung W; Lenhart M; Clevert DA
    Clin Hemorheol Microcirc; 2006; 34(4):483-97. PubMed ID: 16687788
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contrast-enhanced Doppler ultrasonography in the diagnosis of hepatocellular carcinoma and premalignant lesions in patients with cirrhosis.
    Fracanzani AL; Burdick L; Borzio M; Roncalli M; Bonelli N; Borzio F; Maraschi A; Fiorelli G; Fargion S
    Hepatology; 2001 Dec; 34(6):1109-12. PubMed ID: 11731999
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation between the blood supply and grade of malignancy of hepatocellular nodules associated with liver cirrhosis: evaluation by CT during intraarterial injection of contrast medium.
    Hayashi M; Matsui O; Ueda K; Kawamori Y; Kadoya M; Yoshikawa J; Gabata T; Takashima T; Nonomura A; Nakanuma Y
    AJR Am J Roentgenol; 1999 Apr; 172(4):969-76. PubMed ID: 10587130
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The usefulness of 1.5 harmonic imaging ultrasonography with Levovist in the diagnosis of focal hepatic tumors.
    Yamamoto K; Shiraki K; Nakanishi S; Fuke H; Hashimoto A; Shimizu A; Nakano T
    Int J Oncol; 2005 Oct; 27(4):989-95. PubMed ID: 16142315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical evaluation of dynamic MRI in the re-diagnosis of therapeutic effect and recurrence after transcatheter arterial embolization for hepatocellular carcinoma].
    Kuwata Y; Hirota S; Sugimoto K; Koshino T; Nishida Y; Tomita M; Matsumoto S; Sako M; Kono M
    Gan To Kagaku Ryoho; 1994 Jul; 21(8):1235-40. PubMed ID: 8031167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validation of preclinical multiparametric imaging for prediction of necrosis in hepatocellular carcinoma after embolization.
    Braren R; Altomonte J; Settles M; Neff F; Esposito I; Ebert O; Schwaiger M; Rummeny E; Steingoetter A
    J Hepatol; 2011 Nov; 55(5):1034-40. PubMed ID: 21354233
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Percutaneous ablation therapy guided by contrast-enhanced sonography for patients with hepatocellular carcinoma.
    Numata K; Isozaki T; Ozawa Y; Sakaguchi T; Kiba T; Kubota T; Ito A; Sugimori K; Shirato K; Morimoto M; Tanaka K
    AJR Am J Roentgenol; 2003 Jan; 180(1):143-9. PubMed ID: 12490493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contrast-enhanced subtraction harmonic sonography for evaluating treatment response in patients with hepatocellular carcinoma.
    Ding H; Kudo M; Onda H; Suetomi Y; Minami Y; Maekawa K
    AJR Am J Roentgenol; 2001 Mar; 176(3):661-6. PubMed ID: 11222201
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of enhancement patterns of focal nodular hyperplasia in contrast-enhanced, wide-band phase-inversion harmonic power Doppler imaging of the liver.
    Janica J; Serwatka W; Polaków J; Ustymowicz A; Walecki J; Ladny JR; Dobrzycki S
    Med Sci Monit; 2004 Jun; 10 Suppl 3():17-21. PubMed ID: 16538193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Additional value of SPIO-enhanced MR imaging for the noninvasive imaging diagnosis of hepatocellular carcinoma in cirrhotic liver.
    Yoo HJ; Lee JM; Lee JY; Kim SH; Kim SJ; Han JK; Choi BI
    Invest Radiol; 2009 Dec; 44(12):800-7. PubMed ID: 19838119
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Probability of hepatocellular carcinoma of small hepatocellular nodules undetectable by computed tomography during arterial portography.
    Tanaka Y; Sasaki Y; Katayama K; Hiramatsu N; Ito A; Murata H; Enomoto N; Oshita M; Mochizuki K; Tsujii M; Tsuji S; Kasahara A; Tomoda K; Nakamura H; Hayashi N; Hori M
    Hepatology; 2000 Apr; 31(4):890-8. PubMed ID: 10733545
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dynamic contrast-enhanced ultrasound (DCE-US) for easy and rapid evaluation of hepatocellular carcinoma compared to dynamic contrast-enhanced computed tomography (DCE-CT)--a pilot study.
    Egger C; Goertz RS; Strobel D; Lell M; Neurath MF; Knieling F; Scharf M
    Ultraschall Med; 2012 Dec; 33(6):587-92. PubMed ID: 23154871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.